Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leu (Q47368477)
Jump to navigation
Jump to search
scientific article published in October 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leu |
scientific article published in October 1994 |
Statements
1 reference
Hyperoxic reperfusion is required to reduce infarct size after intravenous therapy with perfluorochemical (Fluosol-DA 20%) or its detergent component (poloxamer 188) in a poorly collateralized animal model. Absence of a role of polymorphonuclear leu (English)
1 reference
Kolodgie FD
1 reference
Farb A
1 reference
Virmani R
1 reference
Carlson GC
1 reference
Wilson PS
1 reference
1 October 1994
1 reference
24
1 reference
4
1 reference
1098-1108
1 reference
Identifiers
1 reference